Neoadjuvant Therapy for cT2N0M0 Rectal Cancer?

J Gastrointest Surg. 2022 Feb;26(2):479-482. doi: 10.1007/s11605-021-05125-8. Epub 2021 Sep 10.

Authors

Gustavo A Rubio¹, Roger D Hurst¹, Konstantin Umanskiy¹, Benjamin D Shogan¹, Neil Hyman¹, Kinga Skowron Olortegui²

Affiliations

¹ Section of Colon and Rectal Surgery, Department of Surgery, UChicago Medicine, 5841 S. Maryland Ave, MC 5095, S217, Chicago, IL, 60637, USA.
² Section of Colon and Rectal Surgery, Department of Surgery, UChicago Medicine, 5841 S. Maryland Ave, MC 5095, S217, Chicago, IL, 60637, USA. kskowron@bsd.uchicago.edu.

PMID: 34506020
DOI: 10.1007/s11605-021-05125-8

No abstract available

Keywords: Clinical staging; Early-stage rectal cancer; Neoadjuvant chemoradiation; Total neoadjuvant therapy; cT2N0M0.

MeSH terms

Chemoradiotherapy
Humans
Neoadjuvant Therapy*
Neoplasm Staging
Rectal Neoplasms* / pathology
Rectal Neoplasms* / surgery
Retrospective Studies